Noxopharm
is an Australia-based biotechnology company that researches and develops oncotoxic and immuno-oncology molecule drugs to treat cancer and inflammatory diseases... Read moreNoxopharm
is an Australia-based biotechnology company that researches and develops oncotoxic and immuno-oncology molecule drugs to treat cancer and inflammatory diseases... Read more
News
Apr 14, 2026
Finance News Network
Noxopharm: Noxopharm Announces CEO Resignation
Feb 12, 2026
LabOnline
Noxopharm: Noxopharm says paper reveals science behind its immune system platform
Aug 25, 2025
TipRanks
Noxopharm: Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN
Jun 11, 2025
Finance News Network
Noxopharm: Noxopharm's Sofra Platform Shows Promising Results
Feb 25, 2025
Finance News Network
Noxopharm: Noxopharm Reports Half-Year Results with Discipline in Cost Management
Feb 06, 2025
Noxopharm Youtube Channel
Noxopharm posted a video "SOF-SKN 2025 video" on YOUTUBE
Oct 10, 2024
Proactive Investors
Noxopharm: Noxopharm 'a step closer to the clinic' upon signing manufacturer for SOF-SKN production
Sep 06, 2024
Proactive Investors
Noxopharm: Noxopharm secures $1.8 million in advanced funding ahead of research and development rebate
Sep 03, 2024
Proactive Investors
Noxopharm: Noxopharm brain cancer drug candidates significantly reduce tumour growth
Aug 28, 2024
Marketscreener
Noxopharm: Noxopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2024
Noxopharm Competitors
1
2
3
4
5
6
7
8
9
10